Inventor
ZANG XINGXING
US13 patents
⚠️ This page may combine multiple inventors who share the name “ZANG XINGXING”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ALBERT EINSTEIN COLLEGE MEDICINE
10 patentsUS11377494B2Jul 5, 2022
Antagonist antibodies against human immune checkpoint CEACAM1 (CD66a) and formulations, kits, and methods of use thereof
ALBERT EINSTEIN COLLEGE MEDICINE2 citations71
US12145989B2Nov 19, 2024
Antagonist antibodies against human immune checkpoint CEACAM1 (CD66a) and formulations, kits, and methods of use thereof
ALBERT EINSTEIN COLLEGE MEDICINE0 citations60
US11261253B2Mar 1, 2022
HHLA2 as a novel inhibitor of human immune system and uses thereof
ALBERT EINSTEIN COLLEGE MEDICINE1 citations60
US10689432B2Jun 23, 2020
B7X and its derivatives for treating and preventing cardiovascular disease
ALBERT EINSTEIN COLLEGE MEDICINE1 citations60
US12221489B2Feb 11, 2025
Antibodies to human B7x for treatment of metastatic cancer
ALBERT EINSTEIN COLLEGE MEDICINE0 citations57
US10882893B2Jan 5, 2021
TMIGD2 and its derivatives as blockers or binders of cancer-expressed HHLA2 for immunotherapies
ALBERT EINSTEIN COLLEGE MEDICINE0 citations53
US12263203B2Apr 1, 2025
BTNL9 and ERMAP as novel inhibitors of the immune system for immunotherapies
ALBERT EINSTEIN COLLEGE MEDICINE0 citations51
US12534527B2Jan 27, 2026
KIR3DL3 is an inhibitory receptor of the immune system and uses thereof
ALBERT EINSTEIN COLLEGE MEDICINE0 citations50
US12252538B2Mar 18, 2025
Monoclonal antibodies against IgV domain of B7-H3 and uses thereof
ALBERT EINSTEIN COLLEGE MEDICINE0 citations50
US12134645B2Nov 5, 2024
Monoclonal antibodies against human tim-3
ALBERT EINSTEIN COLLEGE MEDICINE0 citations50